Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Guidelines for submitting adverse event reports for publication.

William N Kelly¹, Felix M Arellano, Joanne Barnes

¹William N. Kelly Consulting, Inc., Oldsmar, Florida 34677, USA. wnkelly@earthlink.net

Pharmacoepidemiology and Drug Safety

|May 2, 2007

Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Rarely reported cases of hepatotoxicity associated with turmeric- and curcuminoid-containing dietary supplements: a comprehensive review by USP.

Pharmaceutical biology·2026

Same author

New Zealand green-lipped mussel (kuku).

Journal of primary health care·2026

Same author

Deciphering the miR-29c-3p / TET3 regulatory axis within the SARS-CoV-2-infected midbrain.

Virology·2026

Same author

Earthworm-mediated partitioning of PFOA and PFOS among solid, dissolved organic, and biological phases during sludge vermicomposting.

Bioresource technology·2026

Same author

Perturbation Solutions for Laminar Flow of a Carreau-Yasuda Fluid in Annular Pipes.

Annals of the New York Academy of Sciences·2026

Same author

Deep-learning-based radiomics of intratumoral and peritumoral CT images to differentiate benign from malignant parotid tumors.

American journal of cancer research·2026

Same journal

A Drug-Environment Interaction Between PM<sub>2</sub> <sub>.5</sub> Concentration and Corticosteroid Use on Cardiovascular and Thromboembolic Events in Older Adults.

Pharmacoepidemiology and drug safety·2026

Same journal

Association Between Socioeconomic Conditions and Biologic Prescriptions for Inflammatory Bowel Diseases in the Brazilian Public Healthcare System: An Ecological Study.

Pharmacoepidemiology and drug safety·2026

Same journal

Effectiveness of Metformin in Preventing Colorectal Cancer Among Japanese Patients With Type 2 Diabetes: A Target Trial Emulation.

Pharmacoepidemiology and drug safety·2026

Same journal

Trends in Pharmacist-Prescribed Dispensing Records of HIV Pre-Exposure (2020-2025) and Post-Exposure Prophylaxis (2020-2024) in Brazil: A Time Series Analysis.

Pharmacoepidemiology and drug safety·2026

Same journal

French Consumption of Methylphenidate in Primary Care From 2016 to 2023, Impact of Prescribing Policy Changes-A Time-Series Analysis.

Pharmacoepidemiology and drug safety·2026

Same journal

Uptake and Use of Biologic Therapies in Paediatric Immune-Mediated Inflammatory Diseases: An Australian Population-Based Study.

Pharmacoepidemiology and drug safety·2026

See all related articles

This summary is machine-generated.

Publishing drug adverse event case reports is crucial for safety surveillance. However, many reports lack vital details, limiting their usefulness. New guidelines aim to improve the quality and impact of these essential safety publications.

Area of Science:

Pharmacovigilance and Drug Safety
Medical Device Surveillance
Herbal and Complementary Medicine Safety

Background:

Publication of adverse event case reports is vital for postmarketing surveillance of drugs, vaccines, biologicals, devices, and complementary medicines.
Deficiencies in published case report details often hinder differential diagnosis, cause-effect assessment, and biological plausibility, limiting their value.
Many major journals have inadequate or nonexistent requirements for publishing adverse event reports.

Purpose of the Study:

To propose essential information that should always be included in published adverse event case reports.
To enhance the quality and utility of case reports for postmarketing surveillance and risk assessment.
To provide guidelines endorsed by the International Society for Pharmacoepidemiology (ISPE) and the International Society of Pharmacovigilance (ISoP).

Related Experiment Videos

Main Methods:

Literature review of existing requirements for publishing adverse event reports.
Analysis of collective experience in reviewing case reports within regulatory, academic, and industry settings.
Development of proposed guidelines for essential information in case report publications.

Main Results:

Identification of critical information gaps in many published adverse event case reports.
Formulation of a comprehensive list of recommended inclusions for case report publications.
Endorsement of the proposed guidelines by ISPE and ISoP.

Conclusions:

Adoption of these guidelines by biomedical journals will improve the quality of published adverse event reports.
Enhanced case reports will provide more reliable signals for drug and medical product risk assessment.
Incorporation of these guidelines into healthcare education curricula is encouraged to improve reporting standards.